A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations. - Roche, Michael; Salimi, Hamid; Duncan, Renee; Wilkinson, Brendan L.; Chikere, Kelechi; Moore, Miranda S.; Webb, Nicholas E.; Zappi, Helena; Sterjovski, Jasminka; Flynn, Jacqueline K.; Ellett, Anne; Gray, Lachlan R.; et al. (Retrovirology, 2013)